Table IV.
Association of risk between high EGFR levels and CAD based on OR.
A, CAD | |||||||
---|---|---|---|---|---|---|---|
Unadjusted | Adjusted | ||||||
Model | OR | 95% CI | P-value | Model | OR | 95% CI | P-value |
EGFR | 3.51 | 2.09–5.87 | ≤0.001 | EGFR | 3.51 | 1.96–6.28 | ≤0.001 |
B, Stable angina | |||||||
Unadjusted | Adjusted | ||||||
Model | OR | 95% CI | P-value | Model | OR | 95% CI | P-value |
EGFR | 2.73 | 1.47–5.07 | ≤0.001 | EGFR | 2.58 | 1.25–5.33 | 0.01 |
C, Myocardial infarction | |||||||
Unadjusted | Adjusted | ||||||
Model | OR | 95% CI | P-value | Model | OR | 95% CI | P-value |
EGFR | 4.25 | 2.28–7.89 | ≤0.001 | EGFR | 3.82 | 1.94–7.52 | ≤0.001 |
Association of EGFR levels with CAD, stable angina, and myocardial infarction. The logistic regression models were adjusted for hypertension, diabetes mellitus and current smoking status. EGFR, epidermal growth factor receptor; CAD, coronary artery disease; OR, odds ratio; CI, confidence intervals.